Tetanus in Italy 2001-2010: A continuing threat in older adults

Vaccine

Volumn 32, Issue 6, 2014, Pages 639-644

  Filia, Antonietta ^a   Bella, Antonino ^a   von Hunolstein, Christina ^a   Pinto, Antonella ^a   Alfarone, Giovanna ^a   Declich, Silvia ^a   Rota, Maria Cristina ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Adults; Epidemiology; Hospital admissions; Immunity; Mortality; Tetanus

Indexed keywords

TETANUS ANTIBODY; TETANUS TOXOID;

ADULT; AGE; ARTICLE; DEATH; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFECTION SENSITIVITY; ITALY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PRIORITY JOURNAL; SEROPREVALENCE; SEX DIFFERENCE; TETANUS; VACCINATION;

ADULTS; EPIDEMIOLOGY; HOSPITAL ADMISSIONS; IMMUNITY; MORTALITY; TETANUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; ITALY; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES; TETANUS; VACCINATION; YOUNG ADULT;

EID: 84893008612     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.12.012     Document Type: Article

References (37)

1. Thwaites C.L., Yen L.M. Tetanus. Harrison's Principles of Internal Medicine 2012, vol. 1:1197-1200. McGraw Hill Professional, New York. 18th ed.
2. Ministero della Salute. Malattie infettive e vaccinazioni. Coperture vaccinali. (Italian Ministry of Health. Infectious diseases and vaccines. Vaccination coverage) (Italian), [accessed 04.09.13]. http://www.salute.gov.it/imgs/C_17_pagineAree_811_listaFile_itemName_13_file.pdf.
3. ICONA Working Group. ICONA 2008: national vaccination coverage survey among children and adolescents. Rapporti Istisan 09/29. Istituto Superiore di Sanita', Rome (Italy), 2009 (Italian), [accessed 04.09.13]. http://www.iss.it/binary/publ/cont/09_29_web.pdf.
4. Pedalino B., Cotter B., Ciofi degli Atti M., Mandolini D., Parroccini S., Salmaso S. Epidemiology of tetanus in Italy in years 1971-2000. Euro Surveill 2002, 7(7):103-110. http://www.eurosurveillance.org/em/v07n07/0707-221.asp [accessed 04.09.13].
5. Italian Ministry of Health. Decree N. 16 of 11 November 1996. Tetanus prophylaxis measures. (Circolare n̊16 del 11 novembre 1996. Tetano: misure di profilassi), (Italian) [accessed 04.09.13]. http://www.levaccinazioni.it/Professionisti/Documenti/legislazione.htm%23tetano.
6. Italian National Institute of Statistics (ISTAT). Demography in Figures, [accessed 09.09.13]. http://www.demo.istat.it/index_e.html.
7. Aggerbeck H., Norgaard-Pedersen B., Heron I. Simultaneous quantitation of diphtheria and tetanus antibodies by double antigen, time-resolved fluorescence immunoassay. J Immunol Methods 1996, 190:171-183.
8. Simonsen O. Vaccination against tetanus and diphtheria. Dan Med Bull 1989, 36:24-47.
9. Borrow R., Balmer P., Roper M.H. The immunological basis for immunizationseries, module 3: tetanus. Update 2006 2007, WHO, Geneva.
10. Quinn H.E., McIntyre P.B. Tetanus in the elderly - an important preventable disease in Australia. Vaccine 2007, 25:1304-1309.
11. Centers for Disease Control Prevention Tetanus surveillance - UnitedStates, 2001-2008. MMWR 2011, 60(12):365-369.
12. Public Health Agency of Canada. Case Definitions for Communicable Diseases under National Surveillance - 2009. Canada Communicable Disease Report 2009. Volume 35S2, [accessed 09.09.13]. http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/09vol35/35s2/Tetan-eng.php.
13. Australian Government Department of Health and Ageing Vaccine preventable diseases in Australia, 2005-2007. Communicable Diseases Intelligence 2010, 34(3). http://www.health.gov.au/internet/publications/publishing.nsf/Content/cda-cdi34suppl.htm~cda-cdi34suppl-3-vpd.htm~cda-cdi34suppl-3-vpd15.htm [accessed 22.11.13].
14. European Centre for Disease Prevention and Control Annual epidemiological report 2012. Reporting on 2010 surveillance data and 2011 epidemic intelligence data 2013, ECDC, Stockholm, http://ecdc.europa.eu/en/publications/Publications/Annual-Epidemiological-Report-2012.pdf [accessed 04.09.13].
15. Commission of the European Communities. Commission Decision of 28 April 2008 amending Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119/98/EC of the European Parliament and of the Council. Official Journal of the European Union 18.6.2008, http://eur-lex.europa.eu/lexuriserv/lexuriserv.do?uri=oj:l:2008:159:0046:0090:en:pdf [accessed 9.09.13].
16. Reddy P., Black T.P. Clostridium tetani (tetanus). Mandell Douglas and Bennett's principles and practice of infectious diseases 2010, Churchill Livingstone, Philadelphia. 7th ed.
17. Tejpratap S.P., Tiwari M.D. Tetanus. Manual for the surveillance of vaccine-preventable diseases 2011, [accessed 22.11.13]. http://www.cdc.gov/vaccines/pubs/surv-manual/chpt16-tetanus.pdf, 5th ed.
18. Gidding H.F., Backhouse J.L., Burgess M.A., Gilbert G.L. Immunity to diphtheria and tetanus in Australia: a national serosurvey. Med J Aust 2005, 183(6):301-304.
19. Yuan L., Lau W., Thipphawong J., Kasenda M., Xie F., Bevilacqua J. Diphteria and tetanus immunity among blood donors in Toronto. Can Med Assoc J 1997, 156(7):985-990.
20. McQuillan G.M., Kruszon D., Deforest A., Chu S., Wharton M. Serologic immunity to diphteria and tetanus in the United States. Ann Intern Med 2002, 136(9):660-666.
21. Steens A., Mollema L., Berbers G.A.M., van Gageldonk P.G.M., van der Klis F.R., de Melker H.E. High tetanus antitoxin antibody concentrations in the Netherlands: a seroepidemiological study. Vaccine 2010, 28:7803-7809.
22. Starka K., Schönfelda C., Bargb J., Molzc B., Vornwaldb A., Bienz U. Seroprevalence and determinants of diphtheria, tetanus and poliomyelitis antibodies among adults in Berlin, Germany. Vaccine 1999, 17(7-8):844-850.
23. Olander R.M., Auranen K., Härkänen T., Leino T. High tetanus and diphtheria antitoxin concentrations of Finnish adults - time for new booster recommendations. Vaccine 2009, 27:5295-5298.
24. Rushdy A.A., White J.M., Ramsay M.E., Crowcroft N.S. Tetanus in England and Wales, 1984-2000. Epidemiol Infect 2003, 130:71-77.
25. Bertoncello L., Milani S., Ferro A., Michieletto F. Il tetano non fa piu' paura Prevento - Dati e Note per la Prevenzione nel Veneto 2005, vol. 2:11. [in Italian] http://www.prevento.it/downloads/pdf/prevento002.pdf [accessed 04.09.13].
26. Advisory Committee on Immunization Practices (ACIP) Notice to Readers Assessing Adult Vaccination Status at Age 50 Years, MMWR 1995/44(29);561-563, [accessed 04.09.13]. http://www.cdc.gov/mmwr/preview/mmwrhtml/00038249.htm.
27. Wagner K.S., White J.M., Andrews N.J., Borrow R., Stanford E., Newton E., et al. Immunity to tetanus and diphtheria in the UK in 2009. Vaccine 2012, 30:7111-7117.
28. Australian Government Department of Health and Ageing Australian immunisation handbook 2013, [accessed 09.09.13]. http://www.health.gov.au/internet/immunise/publishing.nsf/Content/handbook10-4-19, 10th ed.
29. Siegrist C.A. New Swiss recommendations for adult boosters against pertussis, tetanus and diphtheria. Rev Med Suisse 2012, 8(324):125-128. [Article in French].
30. Gardner P. Issues related to the decennial tetanus - diphtheria toxoid booster recommendations in adults. Infect Dis Clin N Am 2001, 15(1):143.
31. Balestra D.J., Littenberg B. Should adult tetanus immunization be given as a single vaccination at age 65α A cost-effectiveness analysis. J Gen Intern Med 1993, 8(8):405-412.
32. Mathias R.G., Schechter M.T. Booster immunization for diphtheria and tetanus: no evidence of need in adults. Lancet 1985, 1(8437):1089-1091.
33. Gonçalves G., Santos M.A., Frade J.G., Cunha J.S. Levels of diphtheria and tetanus specific IgG of Portuguese adult women, before and after vaccination with adult type Td. Duration of immunity following vaccination. BMC Public Health 2007, 7(June (12)):109.
34. Gardner P., LaForce F.M. Protection against tetanus. New Engl J Med 1995, 333(9):599.
35. Sanford J.P. Tetanus - forgotten but not gone. New Engl J Med 1995, 332(12):812-813.
36. Abbate R., Di Giuseppe G., Marinelli P., Angelillo I.F., Collaborative Working Group Appropriate tetanus prophylaxis in patients attending Emergency Departments in Italy. Vaccine 2008, 26:3634-3639.
37. Edsall G. Editorial: the inexcusable disease. J Am Med Assoc 1976, 235(1):62-63.